Much of the work carried out by DTT is in support of the National Toxicology Program (NTP), an interagency partnership of the Food and Drug Administration, National Institute for Occupational Safety and Health, and NIEHS.
Office of Program Operations
-
-
Laura A. Hall, M.S.
Biologist -
Tel 984-287-3137
[email protected] -
P.O. Box 12233Mail Drop K2-05Durham, NC 27709
Laura Hall is a biologist and assists the Chemistry and ADME Resources Group in the Office of Program Operations in the Division of Translational Toxicology (DTT). She curates legacy DTT toxicokinetic and Absorption, Distribution, Metabolism, and Excretion (ADME) studies for addition to the Chemical Effects in Biological Systems database (CEBS). Hall is also a member of the Developmental Neurotoxicity Health Effects Innovation (DNT HEI) Program management team.
During her career at NIEHS, Hall worked in a laboratory setting, first as a chemist in the Laboratory of Reproductive and Developmental Toxicology, and then as a biologist in the Laboratory of Toxicology and Pharmacology. She spent one year with the NIEHS Office of Communications and Public Liaison as a writer on temporary assignment before moving to the DTT. She serves on the NIEHS Environmental Awareness Advisory Committee.
Hall received her B.A. in Zoology and Chemistry from Duke University in 1976 and a M.S. in Marine Sciences from North Carolina State University in 1982.
Recent Publications
- Perry J, Dembla-Rajpal N, Hall L, Pritchard J. A three-dimensional model of human organic anion transporter 1: aromatic amino acids required for substrate transport. The Journal of biological chemistry. 2006 Dec 08;281(49):38071-9. [ AbstractPerry J, Dembla-Rajpal N, Hall L, Pritchard J. A three-dimensional model of human organic anion transporter 1: aromatic amino acids required for substrate transport. The Journal of biological chemistry. 2006 Dec 08 ]
- Bleasby K, Hall L, Perry J, Mohrenweiser H, Pritchard J. Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6). The Journal of pharmacology and experimental therapeutics. 2005 Aug;314(2):923-31. [ AbstractBleasby K, Hall L, Perry J, Mohrenweiser H, Pritchard J. Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6). The Journal of pharmacology and experimental therapeutics. 2005 Aug ]